Two Sigma Advisers’s NextCure NXTC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-4,808
| Closed | -$129K | – | 2611 |
|
|
2024
Q1 | $129K | Hold |
4,808
| – | – | ﹤0.01% | 2282 |
|
|
2023
Q4 | $65.8K | Sell |
4,808
-42
| -0.9% | -$575 | ﹤0.01% | 2374 |
|
|
2023
Q3 | $75.1K | Sell |
4,850
-1,333
| -22% | -$20.6K | ﹤0.01% | 2242 |
|
|
2023
Q2 | $134K | Sell |
6,183
-2,717
| -31% | -$58.7K | ﹤0.01% | 2171 |
|
|
2023
Q1 | $158K | Sell |
8,900
-2,958
| -25% | -$52.5K | ﹤0.01% | 2311 |
|
|
2022
Q4 | $201K | Sell |
11,858
-909
| -7% | -$15.4K | ﹤0.01% | 2190 |
|
|
2022
Q3 | $421K | Buy |
12,767
+4,134
| +48% | +$136K | ﹤0.01% | 1916 |
|
|
2022
Q2 | $487K | Buy |
8,633
+8
| +0.1% | +$451 | ﹤0.01% | 1936 |
|
|
2022
Q1 | $503K | Sell |
8,625
-4,617
| -35% | -$269K | ﹤0.01% | 1984 |
|
|
2021
Q4 | $953K | Sell |
13,242
-3,341
| -20% | -$240K | ﹤0.01% | 1578 |
|
|
2021
Q3 | $1.34M | Buy |
16,583
+8,633
| +109% | +$698K | ﹤0.01% | 1476 |
|
|
2021
Q2 | $766K | Sell |
7,950
-1,533
| -16% | -$148K | ﹤0.01% | 1757 |
|
|
2021
Q1 | $1.14M | Buy |
9,483
+2,358
| +33% | +$283K | ﹤0.01% | 1583 |
|
|
2020
Q4 | $932K | Sell |
7,125
-7,317
| -51% | -$957K | ﹤0.01% | 1592 |
|
|
2020
Q3 | $1.53M | Buy |
14,442
+11,884
| +465% | +$1.25M | ﹤0.01% | 1302 |
|
|
2020
Q2 | $658K | Buy |
+2,558
| New | +$658K | ﹤0.01% | 1769 |
|